Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor with great variation in prognosis among individuals. Changes in metabolism influence disease progression and clinical outcomes. The objective of this study was to determine the overall survival (OS) risk of HCC patients from a metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Jialei, Zhou, Chenhao, Zhou, Qiang, Chen, Wanyong, Yin, Yirui, Atyah, Manar, Dong, Qiongzhu, Shi, Yi, Ren, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018394/
https://www.ncbi.nlm.nih.gov/pubmed/33824863
http://dx.doi.org/10.2147/JHC.S300633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018394/
https://www.ncbi.nlm.nih.gov/pubmed/33824863
http://dx.doi.org/10.2147/JHC.S300633

Ejemplares similares